Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 study evaluating the Latanoprost punctal plug delivery system (L-PPDS) for ocular hypertension or open-angle glaucoma has completed;…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG [Phase 2]
A completed Phase 2 clinical trial evaluating different formulations of L-PPDS in subjects with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial evaluating the safety and efficacy of the Punctum Plug Delivery System in Open-angle glaucoma or ocular hypertension has been …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial results evaluating the safety and efficacy of a triple combination therapy in patients with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) [Phase 2]
A Phase 2 study evaluating latanoprost delivered via a punctal plug system (L-PPDS) for open-angle glaucoma and ocular hypertension has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma [Phase 2]
A Phase 2 safety study evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with ocular hypertension or open-angle g…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 study evaluating whether artificial tears affect the response to a latanoprost punctal plug delivery system in adults with glaucoma …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
Clinical trial update from Allergan indicating a completed study comparing quantitative assessments in open-angle glaucoma and ocular hypert…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) [Phase 4]
Phase 4 study comparing intraocular pressure control in open-angle glaucoma or ocular hypertension patients treated with travoprost 0.004% v…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma [Phase 2]
This document reports the completion of a Phase 2 multiple-dose escalation study of AMA0076 in patients with glaucoma or ocular hypertension…
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% [Phase 2]
A Phase 2 study of brinzolamide 1% / brimonidine 0.2% fixed combination and its individual components in open-angle glaucoma and ocular hype…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% [Phase 3]
Phase 3 study comparing the fixed-dose combination brinzolamide 1%/brimonidine 0.2% to each component alone in open-angle glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of a Brinzolamide/Brimonidine fixed combination for open-angle glaucoma and ocular hypert…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P [NA]
A prospective comparative clinical study evaluating the NON CONTACT TONO/PACHYMETER NT-530P for intraocular pressure measurement has complet…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma [Phase 2]
This Phase 2 dose-finding study evaluates the tolerability and effect on intraocular pressure of SYL040012 in people with ocular hypertensio…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma [Phase 1]
This Phase 1 study evaluated single and multiple dose escalation and a two-sequence crossover design for ONO-9054 in ocular hypertension or …
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops [Phase 3]
Phase 3 trial update examining ocular signs and symptoms when glaucoma patients switched from latanoprost to preservative-free tafluprost ey…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Study of TRAVATAN in Subjects With Iris Pigmentation Changes
This clinical trial update reports termination of a study evaluating TRAVATAN (travoprost) in subjects with open-angle glaucoma or ocular hy…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% [Phase 3]
Phase 3 trial comparing fixed-dose brinzolamide 1%/brimonidine 0.2% versus the individual components brinzolamide 1% and brimonidine 0.2% fo…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) [Phase 4]
Phase 4 clinical trial comparing 24-hour intraocular pressure control between latanoprost and tafluprost in primary open-angle glaucoma or o…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Comparing Eye Pressure Using Maximal Tolerated Local Therapy or Systemic Acetazolamide
A University of Cologne trial compared maximal tolerated local therapy with systemic acetazolamide for lowering elevated intraocular pressur…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing travoprost 0.004%/timolol 0.5% versus latanoprost 0.005%/timolol 0.5% in Chinese patients with open-angle glaucoma o…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect [NA]
This report documents a completed clinical trial evaluating continuous intraocular pressure measurement and its ability to detect treatment …
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies [Phase 3]
Phase 3 superiority study evaluating a preservative-free fixed-dose combination of tafluprost and timolol versus each monotherapy in ocular …
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial comparing a new formulation of bimatoprost/timolol ophthalmic solution with the standard formulation in patients with glauco…